We confirm here that HMGB1 content in PLTs and in their derived MV in high-risk thrombosis patients is increased in comparison with PLTs from HVs of a younger age group and that treatment with aspirin reduces HMGB1 expression in PLTs and in PLT-derived MV. The gene discussed is HMGB1; the disease is deep vein thrombosis.